![logo](/logos/002349.SZ.webp)
Jinghua Pharmaceutical Group Co., Ltd.
SZSE:002349.SZ
9.54 (CNY) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Jinghua Pharmaceutical Group Co., Ltd. |
Symbool | 002349.SZ |
Munteenheid | CNY |
Prijs | 8.74 |
Beurswaarde | 7,115,941,870 |
Dividendpercentage | 1.03% |
52-weken bereik | 8.5 - 17.58 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Yunzhong Zhou |
Website | https://www.jinghuapharm.com |
An error occurred while fetching data.
Over Jinghua Pharmaceutical Group Co., Ltd.
Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. Jinghua Pharmaceutical Group Co., Ltd.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)